当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Leonardo Lodolo , Cinzia Rossi, Claudia Canale, Michelangelo Barbaglia, Giovanna Prandi, Paola Ghiotti4 , Iris Agreiter, Leonardo Pagani, Enrico Finale, Nino Cappuccia and Andrea Guala
The identification and treatment of infections by the stereptococco group B (GBS), or Streptococcus agalactiae in pregnancy, are meant to prevent potential clinical disorders such as endometritis and neonatal sepsis is early onset (EOD) and late (LOD). The purpose of the study was to analyze the methods of collection and cultivation of GBS in all microbiology laboratories of two Italian regions, Piedmont and Valle d'Aosta, in search of a correlation that could explain the remarkable rate variability of outcomes of the test. The study team analyzed 28491 test from 70 public and private laboratories of microbiology, and crossing data with regional registries of births, there was a positive test by an average of 14.6%, range between 2.4% and 22.6%. Further analysis has revealed that the laboratories used an enrichment broth culture showed a positive test of the 15.49% of the cases (±95% CI: 14.78 to 16.23%; range 10.7 to 22.60%), while the samples analyzed without enrichment broth showed a positivity of 10.53% (±95% CI: 10 to 11.08%; range from 2.40 to 20%) (p<0.0000001). The results show that the breach of the guidelines of microbiology generate a high rate of false negatives and how the enrichment broth can be the gold standard for the culture of GBS during pregnancy.